BerandaSTIM • NASDAQ
add
Neuronetics Inc
Tutup sebelumnya
$2,44
Rentang hari
$2,34 - $2,62
Rentang tahun
$0,52 - $5,07
Kapitalisasi pasar
137,46 jt USD
Volume Rata-Rata
687,46 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 18,53 jt | 3,61% |
Biaya operasional | 21,73 jt | 5,30% |
Laba bersih | -13,34 jt | -42,06% |
Margin laba bersih | -72,00 | -37,12% |
Penghasilan per saham | -0,44 | -33,33% |
EBITDA | -7,17 jt | 13,99% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 20,87 jt | -41,79% |
Total aset | 74,12 jt | -20,29% |
Total liabilitas | 64,74 jt | 17,60% |
Total ekuitas | 9,38 jt | — |
Saham yang beredar | 30,35 jt | — |
Harga terhadap nilai buku | 7,87 | — |
Tingkat pengembalian aset | -22,61% | — |
Tingkat pengembalian modal | -27,58% | — |
Arus Kas
Perubahan kas bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -13,34 jt | -42,06% |
Kas dari operasi | -5,42 jt | 46,49% |
Kas dari investasi | 14,00 rb | -78,79% |
Kas dari pembiayaan | -16,37 jt | — |
Perubahan kas bersih | -21,78 jt | -116,49% |
Arus kas bebas | -2,85 jt | 62,41% |
Tentang
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
Didirikan
2003
Kantor pusat
Situs
Karyawan
201